Pradžia › Krono liga › Florida
Krono liga klinikiniai tyrimai Florida
27 tyrimai dėl Krono liga ieško dalyvių vietose Florida.
Miestai Florida
- Miami19 tyrimai
- Orlando17 tyrimai
- Tampa10 tyrimai
- Kendall5 tyrimai
- Jacksonville4 tyrimai
- Hialeah4 tyrimai
- Spring Hill4 tyrimai
- Gainesville3 tyrimai
- Pensacola3 tyrimai
- Town 'n' Country3 tyrimai
- Clearwater3 tyrimai
- Lakeland3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Covenant Metabolic Specialists, LLC ( Site 5150), Fort Myers
- Nature Coast Clinical Research - Inverness ( Site 5042), Inverness
- Sanchez Clinical Research ( Site 5144), Miami
- ir dar 4
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- ir dar 5
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Novum Research /ID# 278128, Clermont
- University of Florida College of Medicine /ID# 266930, Gainesville
- Nature Coast Clinical Research - Inverness /ID# 265874, Inverness
- ir dar 9
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Green Leaf Clinical Trials, Jacksonville
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Center Inc., Lakewood Rch
- ir dar 2
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- West Central Gastroenterology, LLP, d/b/a/ Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- Wellness Clinical Research, Miami Lakes
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
- University of Miami, Miami
Renkami dalyviai
Amžius nuo 16 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07671872An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Novum Research, LLC-Site Number: 8400003, Clermont
- Sarkis Clinical Trials - Gainesville-Site Number: 8400048, Gainesville
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- ir dar 12
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-23 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Bioresearch Partner-Kendale Lakes, Miami
- Endoscopic Research Inc, Orlando
- ir dar 1
Renkami dalyviai2 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Endoscopic Research Inc, Orlando
- Alliance Clinical Research of Tampa, LLC, Tampa
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- GCP Clinical Research, Tampa
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07577843Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-07 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07237516Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
- Digestive & Liver Center of Florida, Orlando
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-16 · NCT06997965Precise Infliximab Exposure and Pharmacodynamic Control
- Nemours Children's Health System-Jacksonville, Jacksonville
Renkami dalyviai2/3 fazė
Amžius nuo 6 iki 22 · Visoms lytims · Atnaujinta 2026-05-05 · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Clinical Research Of Brandon, LLC, Brandon
- West Central Gastroenterology d/b/a Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- ir dar 7
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-04-27 · NCT06456593Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- University of Miami, Miami
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-30 · NCT06774079A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400017, Kissimmee
- Investigational Site Number: 8400015, Lighthouse PT
- Investigational Site Number 8400028, Miami
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-27 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
- Mayo Clinic Florida, Jacksonville
Renkami dalyviai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-02-17 · NCT06647615Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Florida, Gainesville
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-12-10 · NCT06721962Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.